{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T05:39:36Z","timestamp":1772343576404,"version":"3.50.1"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"24","license":[{"start":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T00:00:00Z","timestamp":1662595200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,12,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Purpose<\/jats:title>\n                  <jats:p>Opioid overdose\u2013related deaths continue to rise. Despite public health efforts, there is still variability in obtainment of naloxone, a lifesaving antidote. We share our experience in the implementation of a novel opioid overdose education and naloxone distribution (OEND) program at a large academic medical center.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Collaborative efforts made by pharmacists, pharmacy students, physicians, nurses, and recovery coaches were employed in the design of the program. The service was available Monday through Friday, 9 am to 6 pm, and primarily carried out by pharmacy students on a rotating basis. Services offered included bedside delivery of naloxone and education prior to the day of discharge. In preparation for their role, the pharmacy students were required to complete a series of trainings and competency assessments.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 40 patients were included in the program evaluation. Of the completed consults 96.7% (n = 30) of patients received both counseling and naloxone delivery. Eighty percent of patients had a history of nonfatal opioid overdose, but only 37.5% had naloxone listed as a home medication. OEND services were provided to 66% of individuals with patient-directed discharges.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Implementation of an inpatient OEND program by mobilizing trained student pharmacists is feasible and expands naloxone access to patients during transitions of care. A similar model could be considered in the future for the delivery of harm reduction supplies to this patient population.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ajhp\/zxac252","type":"journal-article","created":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T20:58:49Z","timestamp":1662670729000},"page":"2253-2260","source":"Crossref","is-referenced-by-count":3,"title":["Implementation of a multidisciplinary inpatient opioid overdose education and naloxone distribution program at a large academic medical center"],"prefix":"10.1093","volume":"79","author":[{"given":"Tu Tran","family":"Nguyen","sequence":"first","affiliation":[{"name":"Department of Pharmacy, The Massachusetts General Hospital , Boston, MA"},{"name":"Bouv\u00e9 College of Health Sciences, Northeastern University , Boston, MA , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dinah","family":"Applewhite","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, The Massachusetts General Hospital , Boston, MA"},{"name":"Department of Medicine, Harvard Medical School , Boston, MA , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiona","family":"Cheung","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The Massachusetts General Hospital , Boston, MA"},{"name":"Bouv\u00e9 College of Health Sciences, Northeastern University , Boston, MA , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Jacob","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The Massachusetts General Hospital , Boston, MA"},{"name":"Bouv\u00e9 College of Health Sciences, Northeastern University , Boston, MA , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Mitchell","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The Massachusetts General Hospital , Boston, MA"},{"name":"Bouv\u00e9 College of Health Sciences, Northeastern University , Boston, MA , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,9,8]]},"reference":[{"issue":"11","key":"2022120508531808400_CIT0001","doi-asserted-by":"crossref","first-page":"8","DOI":"10.15585\/mmwr.mm6911a4","article-title":"Drug and opioid-involved overdose deaths \u2014United States, 2017\u20132018","volume":"69","author":"Wilson","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2022120508531808400_CIT0002","author":"Centers for Disease Control and Prevention.","year":"2021"},{"issue":"6","key":"2022120508531808400_CIT0003","doi-asserted-by":"crossref","first-page":"202","DOI":"10.15585\/mmwr.mm7006a4","article-title":"Trends and geographic patterns in drug and synthetic opioid overdose deaths \u2014 United States, 2013\u20132019","volume":"70","author":"Mattson","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"2022120508531808400_CIT0004","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/YCO.0000000000000717","article-title":"The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis","volume":"34","author":"Ciccarone","year":"2021","journal-title":"Curr Opin Psychiatry"},{"key":"2022120508531808400_CIT0005","author":"Centers for Disease Control and Prevention."},{"key":"2022120508531808400_CIT0006","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13722-016-0068-3","article-title":"Opioid overdose prevention and naloxone rescue kits: what we know and what we don\u2019t know","volume":"12","author":"Kerensky","year":"2017","journal-title":"Addict Sci Clin Pract"},{"key":"2022120508531808400_CIT0007","doi-asserted-by":"crossref","first-page":"f174","DOI":"10.1136\/bmj.f174","article-title":"Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis","volume":"346","author":"Walley","year":"2013","journal-title":"BMJ"},{"key":"2022120508531808400_CIT0008","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.addbeh.2018.03.014","article-title":"Opioid-overdose laws association with opioid use and overdose mortality","volume":"86","author":"McClellan","year":"2018","journal-title":"Addict Behav"},{"key":"2022120508531808400_CIT0009","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3389\/fsoc.2021.619683","article-title":"Community case study of naloxone distribution by hospital-based harm reduction program for people who use drugs in New York City","volume":"6","author":"Riazi","year":"2021","journal-title":"Front Sociol"},{"issue":"11","key":"2022120508531808400_CIT0010","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1016\/j.ajem.2018.03.066","article-title":"Naloxone access among an urban population of opioid users","volume":"36","author":"Nikolaides","year":"2018","journal-title":"Am J Emerg Med"},{"issue":"5","key":"2022120508531808400_CIT0011","doi-asserted-by":"crossref","first-page":"e210393","DOI":"10.1001\/jamahealthforum.2021.0393","article-title":"Trends in filled naloxone prescriptions before and during the COVID-19 pandemic in the United States","volume":"2","author":"O\u2019Donoghue","year":"2021","journal-title":"JAMA Health Forum"},{"issue":"2","key":"2022120508531808400_CIT0012","doi-asserted-by":"crossref","first-page":"105","DOI":"10.9740\/mhc.2019.03.105","article-title":"Evaluation and optimization of take-home naloxone in an academic medical center","volume":"9","author":"Cooler","year":"2019","journal-title":"Ment Health Clin"},{"issue":"6","key":"2022120508531808400_CIT0013","first-page":"364","article-title":"Increasing naloxone prescribing in the emergency department through education and electronic medical record work-aids","volume":"47","author":"Funke","year":"2021","journal-title":"Jt Comm J Qual Patient Saf"},{"issue":"1","key":"2022120508531808400_CIT0014","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.japh.2021.10.011","article-title":"Analysis of naloxone access and primary medication nonadherence in a community pharmacy setting","volume":"62","author":"Connolly","year":"2022","journal-title":"J Am Pharm Assoc"},{"key":"2022120508531808400_CIT0015","author":"Commonwealth of Massachusetts."},{"key":"2022120508531808400_CIT0016","author":"Boston University School of Medicine."},{"key":"2022120508531808400_CIT0017","author":"Delvalle Institute, Boston Public Health Commission."},{"key":"2022120508531808400_CIT0018","author":"The General Court of the Commonwealth of Massachusetts."},{"issue":"2","key":"2022120508531808400_CIT0019","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap) \u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"issue":"1","key":"2022120508531808400_CIT0020","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/08897077.2018.1518836","article-title":"Development and evaluation of a pilot overdose education and naloxone distribution program for hospitalized general medical patients","volume":"40","author":"Jakubowski","year":"2019","journal-title":"Subst Abuse"},{"issue":"1","key":"2022120508531808400_CIT0021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.annemergmed.2019.07.014","article-title":"Predictors of overdose death among high-risk emergency department patients with substance-related encounters: a data linkage cohort study","volume":"75","author":"Krawczyk","year":"2020","journal-title":"Ann Emerg Med"},{"key":"2022120508531808400_CIT0022","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.drugalcdep.2016.02.024","article-title":"Non-fatal overdose as a risk factor for subsequent fatal overdose among people who inject drugs","volume":"162","author":"Caudarella","year":"2016","journal-title":"Drug Alcohol Depend"},{"key":"2022120508531808400_CIT0023","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.drugpo.2019.03.012","article-title":"Stigma and drug use settings as correlates of self-reported, nonfatal overdose among people who use drugs in Baltimore, Maryland","volume":"68","author":"Latkin","year":"2019","journal-title":"Int J Drug Policy"},{"issue":"1","key":"2022120508531808400_CIT0024","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12954-020-00399-8","article-title":"\u201cThey look at us like junkies\u201d: influences of drug use stigma on the healthcare engagement of people who inject drugs in New York City","volume":"17","author":"Muncan","year":"2020","journal-title":"Harm Reduct J"},{"key":"2022120508531808400_CIT0025","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.drugalcdep.2019.01.037","article-title":"Strategies used by people who inject drugs to avoid stigma in healthcare settings","volume":"198","author":"Biancarelli","year":"2019","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"2022120508531808400_CIT0026","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12954-019-0285-7","article-title":"\u201cMaybe if I stop the drugs, then maybe they\u2019d care?\u201d\u2014hospital care experiences of people who use drugs","volume":"16","author":"Chan Carusone","year":"2019","journal-title":"Harm Reduct J"},{"issue":"12","key":"2022120508531808400_CIT0027","doi-asserted-by":"crossref","first-page":"e22411","DOI":"10.2196\/22411","article-title":"Reasons people who use opioids do not accept or carry no-cost naloxone: qualitative interview study","volume":"4","author":"Bennett","year":"2020","journal-title":"JMIR Form Res"},{"issue":"8","key":"2022120508531808400_CIT0028","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1001\/jamapsychiatry.2018.1471","article-title":"Causes of death after nonfatal opioid overdose","volume":"75","author":"Olfson","year":"2018","journal-title":"JAMA Psychiatry"},{"key":"2022120508531808400_CIT0029","author":"National Harm Reduction Coalition."},{"issue":"11","key":"2022120508531808400_CIT0030","doi-asserted-by":"crossref","first-page":"8077","DOI":"10.5688\/ajpe8077","article-title":"A curriculum crosswalk of the core entrustable professional activities for new pharmacy graduates","volume":"84","author":"Kanmaz","year":"2020","journal-title":"Am J Pharm Educ"},{"issue":"2","key":"2022120508531808400_CIT0031","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1016\/j.japh.2020.10.010","article-title":"Pharmacist counseling when dispensing naloxone by standing order: a secret shopper study of 4 chain pharmacies","volume":"61","author":"Contreras","year":"2021","journal-title":"J Am Pharm Assoc"},{"issue":"4","key":"2022120508531808400_CIT0032","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1080\/08897077.2019.1616349","article-title":"Pharmacists\u2019 attitudes toward dispensing naloxone and medications for opioid use disorder: a scoping review of the literature","volume":"40","author":"Muzyk","year":"2019","journal-title":"Subst Abuse"},{"issue":"6","key":"2022120508531808400_CIT0033","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.japh.2019.08.009","article-title":"Attitudes and perceptions of naloxone dispensing among a sample of Massachusetts community pharmacy technicians","volume":"59","author":"Kurian","year":"2019","journal-title":"J Am Pharm Assoc"},{"key":"2022120508531808400_CIT0034","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2147\/IPRP.S244709","article-title":"Considering the potential benefits of over-the-counter naloxone","volume":"10","author":"Evoy","year":"2021","journal-title":"Integr Pharm Res Pract"},{"issue":"4","key":"2022120508531808400_CIT0035","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1111\/1475-6773.13125","article-title":"Will converting naloxone to over-the-counter status increase pharmacy sales?","volume":"54","author":"Murphy","year":"2019","journal-title":"Health Serv Res"},{"issue":"22","key":"2022120508531808400_CIT0036","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1056\/NEJMsa1912403","article-title":"FDA initiative for drug facts label for over-the-counter naloxone","volume":"382","author":"Cohen","year":"2020","journal-title":"N Engl J Med"},{"issue":"11","key":"2022120508531808400_CIT0037","doi-asserted-by":"crossref","first-page":"ofaa503","DOI":"10.1093\/ofid\/ofaa503","article-title":"Opportunities to offer harm reduction to people who inject drugs during infectious disease encounters: narrative review","volume":"7","author":"Peckham","year":"2020","journal-title":"Open Forum Infect Dis"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajhp\/advance-article-pdf\/doi\/10.1093\/ajhp\/zxac252\/46223633\/zxac252.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajhp\/article-pdf\/79\/24\/2253\/47562256\/zxac252.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajhp\/article-pdf\/79\/24\/2253\/47562256\/zxac252.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T08:53:36Z","timestamp":1670230416000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/79\/24\/2253\/6694239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,8]]},"references-count":37,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2022,9,8]]},"published-print":{"date-parts":[[2022,12,5]]}},"URL":"https:\/\/doi.org\/10.1093\/ajhp\/zxac252","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,12,15]]},"published":{"date-parts":[[2022,9,8]]}}}